3970-72-7 Usage
Uses
Used in Pharmaceutical Industry:
4-Methoxy-4-methyl-piperidine is used as a key intermediate for the synthesis of various drugs. Its unique chemical structure allows for the development of new pharmaceutical compounds with potential therapeutic applications.
Used in Agrochemical Industry:
4-Methoxy-4-methyl-piperidine is used as a building block in the synthesis of agrochemicals, such as pesticides and herbicides. Its versatile structure enables the creation of new compounds with improved efficacy and selectivity in agricultural applications.
Used in Organic Chemistry Research:
4-Methoxy-4-methyl-piperidine is utilized as a valuable starting material in the synthesis of complex organic molecules. Its unique structure provides opportunities for further functionalization and modification, contributing to the advancement of organic chemistry research.
Check Digit Verification of cas no
The CAS Registry Mumber 3970-72-7 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 3,9,7 and 0 respectively; the second part has 2 digits, 7 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 3970-72:
(6*3)+(5*9)+(4*7)+(3*0)+(2*7)+(1*2)=107
107 % 10 = 7
So 3970-72-7 is a valid CAS Registry Number.
InChI:InChI=1/C7H15NO/c1-7(9-2)3-5-8-6-4-7/h8H,3-6H2,1-2H3
3970-72-7Relevant academic research and scientific papers
PHTHALAZINONE DERIVATIVES
-
Page/Page column 27-28, (2009/08/14)
A compound of the formula (I): wherein: A and B together represent an optionally substituted, fused aromatic ring; X and Y are selected from CH and CH, CF and CH, CH and CF and N and CH respectively; RC is selected from H, C1-4 alkyl
DIAZACARBAZOLES AND METHODS OF USE
-
Page/Page column 149, (2010/01/07)
The invention relates to 1,7-diazacarbazole compounds of Formula (I), (I-a) and (I-b) which are useful as kinase inhibitors, more specifically useful as checkpoint kinase 1 (chkl) inhibitors, thus useful as cancer therapeutics. The invention also relates to compositions, more specifically pharmaceutical compositions comprising these compounds and methods of using the same to treat various forms of cancer and hyperproliferative disorders, as well as methods of using the compounds for in vitro, in situ, and in vivo diagnosis or treatment of mammalian cells, or associated pathological conditions.
